Wall Street analysts forecast that Synovus Financial (SNV) will report quarterly earnings of $1.25 per share in its upcoming release, pointing to a year-over-year increase of 7.8%. It is anticipated that revenues will amount to $583.84 million, exhibiting an increase of 90.7% compared to the year-ago quarter.Over the last 30 days, there has been an upward revision of 1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsiderati ...

The upcoming report from South Plains Financial (SPFI) is expected to reveal quarterly earnings of $0.77 per share, indicating an increase of 16.7% compared to the year-ago period. Analysts forecast revenues of $51.7 million, representing an increase of 6.4% year over year.The consensus EPS estimate for the quarter has been revised 2.4% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timefra ...

Analysts on Wall Street project that M&T Bank Corporation (MTB) will announce quarterly earnings of $4.03 per share in its forthcoming report, representing an increase of 6.3% year over year. Revenues are projected to reach $2.39 billion, increasing 3.6% from the same quarter last year.The consensus EPS estimate for the quarter has undergone a downward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial ...

In its upcoming report, Progressive (PGR) is predicted by Wall Street analysts to post quarterly earnings of $4.30 per share, reflecting an increase of 62.3% compared to the same period last year. Revenues are forecasted to be $21.52 billion, representing a year-over-year increase of 17.9%.The consensus EPS estimate for the quarter has been revised 1.1% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates d ...

Rhythm Pharmaceuticals, Inc. (RYTM) shares rallied 36.6% in the last trading session to close at $89. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.3% loss over the past four weeks.The stock rallied after the company announced positive top-line data from a phase II study evaluating its investigational oral melanocortin-4 receptor (MC4R) agonist, bivamelagon, in patients with acquired hypothalamic obesity. ...

Vir Biotechnology, Inc. (VIR) shares soared 11.9% in the last trading session to close at $5.93. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.2% loss over the past four weeks.The sudden rise in the stock price can be attributed to the positive investor mindset regarding the potential of Vir Biotechnology’s only late-stage pipeline candidate, tobevibart. It is being developed in combination with Alnylam’s elebsiran, in a regi ...

MiMedx (MDXG) shares soared 8% in the last trading session to close at $7. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.5% gain over the past four weeks.The sudden rise in price can be attributed to growing investors’ optimism related to the company’s efforts to develop and provide a leading portfolio of products for applications in the wound care, burn and surgical sectors of healthcare.This developer of biomaterials made f ...

Core Viewpoint - Micron Technology Inc's stock is experiencing a decline despite beating fiscal third-quarter earnings and revenue expectations, with significant price-target increases from analysts [1][2]. Group 1: Earnings and Stock Performance - Micron's stock is down 1.7%, trading at $125.06, despite a strong earnings report [1]. - The stock reached a year-to-date peak of $129.85 before reversing gains, indicating volatility in its price movement [3]. - Year-to-date, shares have gained 50.8%, suggesting strong overall performance despite recent declines [3]. Group 2: Analyst Ratings and Price Targets - A total of 26 out of 30 analysts have a "buy" or better rating on Micron, reflecting positive sentiment in the market [2]. - The 12-month consensus price objective for Micron is $137.40, which represents a 7.7% premium over the current stock price [2]. Group 3: Options Trading Activity - Options trading volume is significantly higher than usual, with 139,000 calls and 97,000 puts exchanged, indicating increased investor interest [4]. - The most active option is the weekly 6/27 130-strike call, where new positions are being opened [4]. - Micron's stock has a high Schaeffer's Volatility Scorecard (SVS) score of 96 out of 100, indicating it has historically delivered larger-than-expected price swings [4].

Company Overview - Granite Ridge Resources, Inc. (GRNT) shares increased by 6.7% to close at $6.41, supported by higher trading volume compared to normal sessions [1] - The company is positioned to benefit from rising oil prices due to geopolitical tensions, particularly the conflict between Israel and Iran, which has led to a 13% increase in Brent crude and a 10% increase in West Texas Intermediate (WTI) [2] Financial Performance - Granite Ridge is expected to report quarterly earnings of $0.17 per share, reflecting a year-over-year increase of 30.8%, with revenues projected at $111 million, up 22.5% from the previous year [3] - The consensus EPS estimate for Granite Ridge has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] Market Position - The company operates as a non-operated oil and natural gas exploration and production entity with a diverse portfolio across major U.S. basins, which enhances its operational flexibility and attractiveness in a volatile market [2] - Granite Ridge holds a Zacks Rank of 3 (Hold), indicating a neutral outlook in the current market context [5]

Let's explore what's going on at UnitedHealth right now and dig into the details on what's driving investors to run for the hills. From there, I'll draw some parallels from other businesses that remind me of UnitedHealth's current situation to help asses where the stock could be one year from now. Shares of UnitedHealth Group have sold off considerably this year, as bad news surrounding the company continues to pile up. UnitedHealth Group (UNH 0.39%) has been one of the more interesting case studies in the ...